These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17024356)

  • 21. Fasciola hepatica antioxidant and protease-inhibitor cocktail recombinant vaccines administered five times elicit potent and sustained immune responses in sheep but do not confer protection.
    Cwiklinski K; McEvoy A; López Corrales J; Jewhurst H; Calvani NED; De Marco Verissimo C; Dorey AL; Keane OM; Dalton JP; Lalor R
    Vet Parasitol; 2023 Nov; 323():110049. PubMed ID: 37826973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The field evaluation of albendazole and triclabendazole efficacy against Fasciola hepatica by coproantigen ELISA in naturally infected sheep.
    Novobilský A; Averpil HB; Höglund J
    Vet Parasitol; 2012 Nov; 190(1-2):272-6. PubMed ID: 22818198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle.
    Hutchinson GW; Dawson K; Fitzgibbon CC; Martin PJ
    Vet Parasitol; 2009 Jun; 162(3-4):278-84. PubMed ID: 19375232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep.
    Sexton JL; Milner AR; Panaccio M; Waddington J; Wijffels G; Chandler D; Thompson C; Wilson L; Spithill TW; Mitchell GF
    J Immunol; 1990 Dec; 145(11):3905-10. PubMed ID: 1978849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
    Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
    Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An attempt to vaccinate sheep against Fasciola hepatica using a juvenile fluke antigen sheep antibody complex.
    Sandeman RM; Howell MJ; Campbell NJ
    Res Vet Sci; 1980 Sep; 29(2):255-9. PubMed ID: 6110229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of early treatment with rafoxanide on antipyrine clearance in sheep infected with Fasciola hepatica.
    Benchaoui HA; McKellar QA
    Xenobiotica; 1993 Apr; 23(4):439-48. PubMed ID: 8101676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Sep; 172(3-4):238-48. PubMed ID: 20627418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasciola hepatica: Histological changes in the somatic and reproductive tissues of liver fluke following closantel treatment of experimentally-infected sheep.
    Scarcella S; Hanna RE; Brennan GP; Solana H; Fairweather I
    Vet Parasitol; 2016 Jan; 215():38-47. PubMed ID: 26790736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection and antibody isotype responses against Fasciola hepatica with specific antibody to pIII-displayed peptide mimotopes of cathepsin L1 in sheep.
    Villa-Mancera A; Méndez-Mendoza M
    Vet J; 2012 Oct; 194(1):108-12. PubMed ID: 22513301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the comparative efficacy of a moxidectin plus triclabendazole pour-on solution against adult and immature liver fluke, Fasciola hepatica, in cattle.
    Geurden T; Bartram D; Van Brussel L; Bo L; Scott-Baird E; Rugg D
    Vet Parasitol; 2012 Oct; 189(2-4):227-32. PubMed ID: 22579500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate and adaptive resistance of Indonesian Thin Tail sheep to liver fluke: a comparative analysis of Fasciola gigantica and Fasciola hepatica infection.
    Pleasance J; Raadsma HW; Estuningsih SE; Widjajanti S; Meeusen E; Piedrafita D
    Vet Parasitol; 2011 Jun; 178(3-4):264-72. PubMed ID: 21320754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental infection of liver flukes, Fasciola hepatica and Fascioloides magna, in Bison (Bison bison).
    Foreyt WJ; Drew ML
    J Wildl Dis; 2010 Jan; 46(1):283-6. PubMed ID: 20090045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On farm evaluation of the coproantigen ELISA and coproantigen reduction test in Scottish sheep naturally infected with Fasciola hepatica.
    Gordon DK; Zadoks RN; Stevenson H; Sargison ND; Skuce PJ
    Vet Parasitol; 2012 Jul; 187(3-4):436-44. PubMed ID: 22421492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fasciolinip-1: experimental fasciolicidal activity in sheep].
    Ibarra-Velarde F; Vera-Montenegro Y; Olazarán-Jenkins S; Hernández-Campos A; Castillo-Bocanegra R
    Rev Latinoam Microbiol; 1995; 37(2):171-8. PubMed ID: 8552877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and differential expression of cathepsin L3 alleles from Fasciola hepatica.
    Zawistowska-Deniziak A; Wasyl K; Norbury LJ; Wesołowska A; Bień J; Grodzik M; Wiśniewski M; Bąska P; Wędrychowicz H
    Mol Biochem Parasitol; 2013 Jul; 190(1):27-37. PubMed ID: 23770026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts.
    Hanna RE; Edgar H; Moffett D; McConnell S; Fairweather I; Brennan GP; Trudgett A; Hoey EM; Cromie L; Taylor SM; Daniel R
    Vet Parasitol; 2008 Nov; 157(3-4):222-34. PubMed ID: 18774647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative kinetics of serological and coproantigen ELISA and faecal egg count in cattle experimentally infected with Fasciola hepatica and following treatment with triclabendazole.
    Brockwell YM; Spithill TW; Anderson GR; Grillo V; Sangster NC
    Vet Parasitol; 2013 Sep; 196(3-4):417-26. PubMed ID: 23643623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
    Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L
    Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.